BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ströbel P, Weis CA, Marx A. [Thymic carcinomas]. Pathologe 2016;37:425-33. [PMID: 27538748 DOI: 10.1007/s00292-016-0194-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Liu Y, Zhuang W, Zhao Y. Modified subcostal arch xiphoid thoracoscopic expanded thymectomy for thymic carcinoma: a case report and review of literature. J Cardiothorac Surg 2022;17. [DOI: 10.1186/s13019-022-01981-w] [Reference Citation Analysis]
2 Cafaro A, Bongiovanni A, Di Iorio V, Oboldi D, Masini C, Ibrahim T. Pembrolizumab in a Patient With Heavily Pre-Treated Squamous Cell Thymic Carcinoma and Cardiac Impairment: A Case Report and Literature Review. Front Oncol 2020;10:1478. [PMID: 33014787 DOI: 10.3389/fonc.2020.01478] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
3 Han Z, Zhang J, Zhang K, Zhao Y. Curcumin inhibits cell viability, migration, and invasion of thymic carcinoma cells via downregulation of microRNA‐27a. Phytotherapy Research 2020;34:1629-37. [DOI: 10.1002/ptr.6629] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Krishnan M, Ganti AK. The role of targeted therapy in thymic carcinoma. J Oncol Pharm Pract 2019;25:1712-8. [PMID: 31159657 DOI: 10.1177/1078155219852758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]